Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus

Indinavir is currently used at a fixed dose of 800 mg either three times a day or twice a day in combination with 100 mg of ritonavir. Dosage individualization based on plasma concentration monitoring might, however, be indicated. This study aimed to assess the pharmacokinetic profile of indinavir i...

Disgrifiad llawn

Manylion Llyfryddiaeth

Cyhoeddwyd yn:	Antimicrob Agents Chemother
Prif Awduron:	Csajka, Chantal, Marzolini, Catia, Fattinger, Karin, Décosterd, Laurent A., Telenti, Amalio, Biollaz, Jérôme, Buclin, Thierry
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	American Society for Microbiology (ASM) 2004
Pynciau:	Pharmacology
Mynediad Ar-lein:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC514769/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15328077/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.9.3226-3232.2004
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!